These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 25007177)

  • 1. The glycomic profile of invasive ductal carcinoma of the breast is altered in patients with hypoxic regions: implications for tumor behavior.
    Rêgo MJ; da Silva Filho AF; Cordeiro MF; Santos PB; Beltrão EI
    Folia Histochem Cytobiol; 2014; 52(2):96-103. PubMed ID: 25007177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.
    Lialiaris TS; Kouskoukis A; Georgiou G; Tripsianis G; Fiska A; Giatromanolaki A; Chrisafi S; Sivridis E; Vamvakopoulou DN; Soutopoulou DO; Kiritsaka A; Athanassiou E; Lialios GA; Sotiriou S; Sidiropoulos A; Vamvakopoulos NC
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):106-11. PubMed ID: 20724920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of REDD1-mediated mammalian target of rapamycin pathway and hypoxia-inducible factor-1α regulation in human breast cancer.
    Koo JS; Jung W
    Pathobiology; 2010; 77(6):289-300. PubMed ID: 21266827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
    Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
    Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of androgen receptor in breast cancer and its significance as a prognostic factor.
    Yu Q; Niu Y; Liu N; Zhang JZ; Liu TJ; Zhang RJ; Wang SL; Ding XM; Xiao XQ
    Ann Oncol; 2011 Jun; 22(6):1288-1294. PubMed ID: 21109569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of carbonic anhydrase IX protein in fibrotic foci of mammary invasive ductal carcinomas].
    Li M; Bao L; Cai H; Yang H; Ge W; Ren L; Lu B
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):250-3. PubMed ID: 25975907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival.
    Ikemori RY; Machado CM; Furuzawa KM; Nonogaki S; Osinaga E; Umezawa K; de Carvalho MA; Verinaud L; Chammas R
    PLoS One; 2014; 9(11):e111592. PubMed ID: 25369297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
    Bhargava R; Beriwal S; McManus K; Dabbs DJ
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoxia induces down-regulation of estrogen receptor alpha in human breast cancer].
    Liu GY; Shen KW; Shao ZM; Shen ZZ
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):664-8. PubMed ID: 15777504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc.
    Zeng Y; Danielson KG; Albert TJ; Shapiro IM; Risbud MV
    J Bone Miner Res; 2007 Dec; 22(12):1851-61. PubMed ID: 17592963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
    Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
    Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ.
    Rêgo MJ; Vieira de Mello GS; da Silva Santos CA; Chammas R; Beltrão EI
    Med Mol Morphol; 2013 Jun; 46(2):92-6. PubMed ID: 23381603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of SATB1 protein in the ductal breast carcinoma tissue microarrays - preliminary study.
    Kobierzycki C; Wojnar A; Dziegiel P
    Folia Histochem Cytobiol; 2013; 51(4):333-8. PubMed ID: 24497139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXA1 Expression Significantly Predict Response to Chemotherapy in Estrogen Receptor-Positive Breast Cancer Patients.
    Xu C; Wei Q; Guo J; Zhou JC; Mei J; Jiang ZN; Shen JG; Wang LB
    Ann Surg Oncol; 2015; 22(6):2034-9. PubMed ID: 25707489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ki-67 expression and significance of different molecular subtypes of breast invasive ductal carcinoma].
    Zhou SJ; Guo H
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(36):2895-7. PubMed ID: 24373403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.